hit counter
AstraZeneca PLC (AZN) Stock News Sentiment & Price - Sentifly
AZN - Sentifly



Your watchlist is empty. Go add some tickers to it!

AstraZeneca PLC (AZN)

United Kingdom
Drug Manufacturers - Major
AZN Price and Sentiment
Positive, Negative
Loading chart...
AZN Latest news
Proactive Investors
AstraZeneca facing raised expectations
2021-11-11 10:15

AstraZeneca PLC (LSE:AZN) releases third quarter results on Friday with shareholders feeling good despite the company perhaps not getting the kudos it deserved for its COVID-19 vaccine efforts. Stockbroker AJ Bell noted a positive outlook for the FTSE 100 stalwart, given the recent performance of the shares despite the weight of the COVID-19 vaccine (which is sold at cost and is overall loss making).

24/7 Wall Street
Earnings Previews: AstraZeneca, Bakkt, Hyzon
2021-11-10 12:10

The number of companies reporting quarterly earnings this week has swelled to more than 1,000 as more companies confirm their plans.

Proactive Investors
AstraZeneca in demand as analysts see further upside
2021-11-10 11:19

AstraZeneca PLC (LSE:AZN) was well bid during the afternoon session with analysts revisiting their spreadsheets after a flurry of news. Barclays Capital has moved its price target to £110 from £100 for shares in the Anglo-Swedish drugs giant.

Zacks Investment Research
New Strong Sell Stocks for November 10th
2021-11-10 09:57

AZN, GOLD, NARI, KOP, and TCEHY have been added to the Zacks Rank #5 (Strong Sell) List on November 10, 2021.

AstraZeneca Plans To Set Up Separate Division For Vaccines & Antibody Therapies - Report
2021-11-10 06:56

AstraZeneca plc (NASDAQ: AZN) is reportedly creating a separate division for vaccines and antibody therapies, primarily to focus on its COVID-19 shot and coronavirus treatments after a shaky start during the pandemic. Related Link:  AstraZeneca Looking At Potential Options for COVID-19 Vaccine Business: Reuters.

Zacks Investment Research
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
2021-11-09 12:59

AstraZeneca's(AZN) third-quarter results are expected to reflect the impact of strong demand for new drugs. Investors are likely to focus on sales numbers of AstraZeneca's COVID-19 vaccine.

AstraZeneca to create separate division for vaccines, antibody therapies
2021-11-09 10:51

(Reuters) -AstraZeneca is creating a separate division for vaccines and antibody therapies to be led by senior executive Iskra Rei?, the drugmaker said on Tuesday, as it builds focus on its COVID-19 shot and development of coronavirus treatments.

Seeking Alpha
AstraZeneca: Lagging For A Reason
2021-11-07 01:08

AstraZeneca: Lagging For A Reason

The Motley Fool
These Clinical Results Are Good News for AstraZeneca
2021-11-06 06:34

AstraZeneca shared positive interim results for Imfinzi plus chemotherapy in treating patients with advanced biliary tract cancer.

Seeking Alpha
AstraZeneca: Looking Overvalued
2021-11-06 04:34

AstraZeneca: Looking Overvalued

Loading more news...